← Back to Search

Device

AccuCinch® System for Heart Failure (CorCinch-HFrEF Trial)

N/A
Waitlist Available
Led By Ulrich Jorde, MD
Research Sponsored by Ancora Heart, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Symptom Status: NYHA III-IV (i.e., ambulatory)
Study patient is at least 18-years old
Must not have
Untreated clinically significant coronary artery disease (CAD) requiring revascularization
Renal insufficiency (i.e., eGFR of <30ml/min/1.73m2; Stage 4 or 5 CKD)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30-day
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new device to treat heart failure in patients with reduced ejection fraction.

Who is the study for?
Adults with heart failure and reduced ejection fraction (HFrEF), specifically those with a left ventricular diameter ≥55 mm, ejection fraction between 20-40%, and stable on optimal heart failure therapies. Participants must have certain devices like CRT or ICD implanted for specified durations before enrollment, be able to perform diagnostic tests, follow the study schedule, and have NYHA class III-IV symptoms.
What is being tested?
The trial is testing the AccuCinch® Ventricular Restoration System in patients with HFrEF. It's an early-stage study that's not randomized but is prospective and multi-center. The goal is to see how well this system works in improving heart function by cinching the ventricle.
What are the potential side effects?
While specific side effects are not listed here, potential risks may include complications from device implantation such as bleeding or infection at the access site, allergic reactions to materials used in the device (nitinol, polyester, polyethylene), or worsening of heart function.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have heart issues but can still walk around.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have heart artery disease that hasn't been treated with surgery.
Select...
My kidney function is severely reduced.
Select...
I have an ongoing heart infection.
Select...
I have had surgery or a procedure on my mitral valve.
Select...
I have low blood pressure or need support to maintain my blood circulation.
Select...
I have a heart condition other than dilated cardiomyopathy causing heart failure.
Select...
My body cannot support the AccuCinch® implant due to physical limitations.
Select...
I have a serious issue with my aortic valve or have an artificial one.
Select...
I am currently taking high dose steroids or immunosuppressants.
Select...
I have not had a stroke or major disability from a stroke in the last 3 months.
Select...
I cannot take blood thinners or anti-clotting medications.
Select...
I am not pregnant, using birth control, or breastfeeding.
Select...
I do not have any heart surgery or procedures planned in the next 6 months.
Select...
I cannot walk or carry out any physical activity without discomfort.
Select...
I have severe leakage in my heart's tricuspid valve.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30-day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30-day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Safety measured by device-related or procedure-related major adverse events (MAEs)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: AccuCinch® Ventricular Restoration SystemExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Ancora Heart, Inc.Lead Sponsor
8 Previous Clinical Trials
598 Total Patients Enrolled
6 Trials studying Heart Failure
574 Patients Enrolled for Heart Failure
Michael Zapien, MS, CCRAStudy DirectorAncora Heart, Inc.
3 Previous Clinical Trials
172 Total Patients Enrolled
3 Trials studying Heart Failure
172 Patients Enrolled for Heart Failure
Ulrich Jorde, MDPrincipal InvestigatorMontefiore Medical Center
3 Previous Clinical Trials
70 Total Patients Enrolled
3 Trials studying Heart Failure
70 Patients Enrolled for Heart Failure
Azeem Latib, MDPrincipal InvestigatorMontefiore Medical Center
7 Previous Clinical Trials
335,026 Total Patients Enrolled

Media Library

AccuCinch® Ventricular Restoration System (Device) Clinical Trial Eligibility Overview. Trial Name: NCT03533517 — N/A
Heart Failure Research Study Groups: AccuCinch® Ventricular Restoration System
Heart Failure Clinical Trial 2023: AccuCinch® Ventricular Restoration System Highlights & Side Effects. Trial Name: NCT03533517 — N/A
AccuCinch® Ventricular Restoration System (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03533517 — N/A
~3 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top